A Multidisciplinary Management Framework for the Treatment of Benign Prostatic Hyperplasia with Focus on Homoeopathy: A Review
Background Benign prostatic hyperplasia (BPH) is a globally prevailing urological condition among ageing men. In India, a few epidemiological studies conducted on BPH patients suggest it as the most common pathological condition with an incidence of around 93.3%. Although non-malignant, the condition adversely impacts the quality of life (QoL) in a way similar to that of other non-communicable diseases like diabetes, hypertension and cardiovascular diseases.
Objective This article aims to review the comprehensive management of BPH with focus on homoeopathic treatment.
Methods PubMed, EMBASE, Google Scholar, AYUSH PORTAL and leading homoeopathic journals were searched for articles on BPH and its homoeopathic management.
Results The review offers a holistic framework for management of BPH that is inclusive of modifiable lifestyle factors alongside homoeopathic treatments. It further underscores that the condition may be cost-effectively managed through homoeopathy to bring about better QoL among people with BPH.
Conclusion Lifestyle optimisation and management of metabolic risk factors may reduce the progression of BPH. Homoeopathic medicines are not only useful in effective management of BPH but also cost-effective, safe and non-surgical. However, randomised controlled trials and double-blind studies can be further taken up in future for more precise authentication.
04. September 2020 (online)
Thieme Medical and Scientific Publishers Private Ltd.
- 1 Lee SWH, Chan EMC, Lai YK. The global burden of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a systematic review and meta-analysis. Sci Rep 2017; 7 (01) 7984
- 2 McVary KT. BPH: epidemiology and comorbidities. Am J Manag Care 2006; 12 (05) S122-S128
- 3 Mittal BV, Amin MB, Kinare SG. Spectrum of histological lesions in 185 consecutive prostatic specimens. J Postgrad Med 1989; 35 (03) 157-161
- 4 Mathur SK, Gupta S, Marwah N, Narula A, Singh S, Arora B. Significance of mucin stain in differentiating benign and malignant lesions of prostate. Indian J Pathol Microbiol 2003; 46 (04) 593-595
- 5 Patel ND, Parsons JK. Epidemiology and etiology of benign prostatic hyperplasia and bladder outlet obstruction. Indian J Urol 2014; 30 (02) 170-176
- 6 Roehrborn CG. Benign prostatic hyperplasia: an overview. Rev Urol 2005; 7 (Suppl. 09) S3-S14
- 7 Gupta G, Singh JP, Tandon S. , et al. Evidence based clinical study to assess the usefulness of homoeopathic medicines in patients of benign prostatic hyperplasia. Indian J Res Homoeopathy 2010; 4 (04) 49-56
- 8 Standard Treatment Guidelines in Homoeopathy. Central Council for Research in Homoeopathy, Ministry of AYUSH, Govt. of India 2016 https://www.ccrhindia.nic.in/admnis/admin/showimg.aspx?id=9492 . Accessed May 14, 2020
- 9 Murphy RN. Homoeopathic Medical Repertory. New Delhi, India: B. Jain Publishers (P) Ltd; 2004: 1246
- 10 Schroyens F. Synthesis Repertorium Syntheticum. New Delhi, India: B. Jain Publishers (P) Ltd; 2005: 970
- 11 Knerr CB. Repertory of Hering's Guiding Symptoms of Our Materia Medica. New Delhi, India: B. Jain Publishers (P) Ltd; 2002: 625
- 12 Kent JT. Kent's Repertory of the Homoeopathic Materia Medica. New Delhi, India: B. Jain Publishers (P) Ltd; 2004: 625
- 13 Boericke W. Boericke's New Manual of Homoeopathic MM with Repertory. New Delhi, India: B. Jain Publishers (P) Ltd; 2007: 752
- 14 Reddy RC, Oberai P, Singh V, Nayak C. Treating benign prostatic hyperplasia in elderly men with homoeopathy - a series of eleven cases. Indian J Res Homoeopathy 2009; 4: 37-41
- 15 Gupta G, Singh JP, Tandon S. , et al. Evidence based clinical study to assess the usefulness of homoeopathic medicines in patients of benign prostatic hyperplasia. Indian J Res Homoeopathy 2010; 4: 63-69
- 16 Oberai P, Roja V, Ramesh D. , et al. Homoeopathic medicines in the management of benign prostatic hyperplasia: a multicentric prospective observational study. IJRH 2012; 6: 16-25
- 17 Hati AK, Paital B, Naik KN, Mishra AK, Chainy GB, Nanda LK. Constitutional, organopathic and combined homeopathic treatment of benign prostatic hypertrophy: a clinical trial. Homeopathy 2012; 101 (04) 217-223
- 18 Gupta G, Singh S. Role of homoeopathic medicines in prostate enlargement: a retrospective observational study. Indian J Res Homoeopathy 2016; 10: 266-271
- 19 Sharma B, Mehra P, Oberai P. , et al. Homoeopathic treatment for lower urinary tract symptoms in men with benign prostatic hyperplasia: an open label randomised multicentric placebo-controlled clinical trial. Indian J Res Homoeopathy 2018; 12: 113-124
- 20 Gupta N, Singh R, Saxena KR. Clinical evaluation of homoeopathic medicines in benign prostatic hyperplasia. Homeopathic Links 2019; 32 (02) 82-87
- 21 Gupta G, Singh S. An evidence based case study of benign prostatic hyperplasia. Indian J Res Homoeopath 2012; 6: 26-30
- 22 Ghosh MS, Shil RC, Chakma A. A case of gallstone with prostatomegaly. Indian J Res Homoeopathy 2014; 8: 231-235
- 23 Fatima L, Bhadula AK, Janani L. , et al. A compilation of case reports from Ayush Wellness Clinic, President's Estate, New Delhi, India. J AYUSH: Ayurveda, Yoga, Unani, Siddha Homeopathy 2018; 7 (01) 14-26
- 24 McClure MW. An overview of holistic medicine and complementary and alternative medicine for the prevention and treatment of BPH, prostatitis, and prostate cancer. World J Urol 2002; 20 (05) 273-284
- 25 Ngai H-Y, Yuen KS, Ng C-M, Cheng C-H, Chu SP. Metabolic syndrome and benign prostatic hyperplasia: an update. Asian J Urol 2017; 4 (03) 164-173
- 26 Rył A, Rotter I, Miazgowski T. , et al. Metabolic syndrome and benign prostatic hyperplasia: association or coincidence?. Diabetol Metab Syndr 2015; 7: 94
- 27 Wang JY, Fu YY, Kang DY. The association between metabolic syndrome and characteristics of benign prostatic hyperplasia. Medicine (Baltimore) 2016; 95 (19) e3243